Research boost to improve outcomes for melanoma patients
11 October 2017
More than $3.5 million in competitive funding grants have been awarded to researchers at Melanoma Institute Australia as part of the National Health and Medical Research Council’s (NHMRC) funding outcomes, announced today.
In partnership with The University of Sydney, the boost will support a Practitioner Fellowship, a Career Development Fellowship and a Centre of Research Excellence aimed at driving better outcomes in melanoma.
MIA’s Co-Medical Director, Professor Richard Scolyer, was awarded a Practitioner Fellowship that will aim to utilise the extensive resources at MIA to improve outcomes of patients with difficult and aggressive melanomas.
Epidemiologist Associate Professor Anne Cust received a Career Development Fellowship for her research into skin cancer epidemiology, prevention and screening that will lead to improved patient and population health through impacting clinical practice and health policy.
Chair of MIA’s Research Committee Professor Graham Mann was awarded the Centre of Research Excellence in Melanoma grant. The project will identify the best way to conduct surveillance of high-risk melanoma patients, how to manage a person with melanoma who has a high potential for relapse, and how best to improve support, survivorship and the patient experience.
The funding will help facilitate MIA’s world-leading researchers to continue their ground-breaking work in melanoma research in order to improve outcomes for patients and their families.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.